Researchers found that neural crest stem cells are uniquely capable of reprogramming, challenging current reprogramming ...
Following the game-changing success of Spinraza, a molecular-based therapy that was crucial in the treatment of SMA (Spinal Muscular Atrophy), which used to be one of the leading genetic killers ...
Q3 2024 Earnings Call Transcript November 7, 2024 ClearPoint Neuro, Inc. misses on earnings expectations. Reported EPS is $-0.18 EPS, expectations were $-0.17. Operator: Greetings, and welcome to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback